Sensorion Stock

Sensorion ROE 2024

Sensorion ROE

0

Ticker

ALSEN.PA

ISIN

FR0012596468

WKN

A14SVV

In 2024, Sensorion's return on equity (ROE) was 0, a -100% increase from the -1.06 ROE in the previous year.

Sensorion Aktienanalyse

What does Sensorion do?

The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Sensorion's Return on Equity (ROE)

Sensorion's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Sensorion's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Sensorion's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Sensorion’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Sensorion stock

What is the ROE (Return on Equity) of Sensorion this year?

The ROE of Sensorion this year is 0 undefined.

How has the Return on Equity (ROE) of Sensorion developed compared to the previous year?

The ROE of Sensorion has increased by -100% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Sensorion?

A high ROE indicates that Sensorion generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Sensorion?

A low ROE can indicate that Sensorion is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Sensorion affect the company?

A change in ROE (Return on Equity) of Sensorion can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Sensorion?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Sensorion?

Some factors that can influence Sensorion's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Sensorion pay?

Over the past 12 months, Sensorion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensorion is expected to pay a dividend of 0 EUR.

What is the dividend yield of Sensorion?

The current dividend yield of Sensorion is .

When does Sensorion pay dividends?

Sensorion pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensorion?

Sensorion paid dividends every year for the past 0 years.

What is the dividend of Sensorion?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensorion located?

Sensorion is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensorion kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensorion from 10/3/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Sensorion pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Sensorion in the year 2023?

In the year 2023, Sensorion distributed 0 EUR as dividends.

In which currency does Sensorion pay out the dividend?

The dividends of Sensorion are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sensorion

Our stock analysis for Sensorion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.